David A. Grimes

Active 1976–2025

128
Papers
24,846
Citations
87
h-index
125
i10-index

Citations

Citations per year for David A. Grimes1978: 1 citations1979: 3 citations1980: 1 citations1982: 1 citations1983: 2 citations1984: 1 citations1985: 1 citations1986: 4 citations1987: 5 citations1988: 8 citations1989: 3 citations1990: 7 citations1991: 11 citations1992: 7 citations1993: 14 citations1994: 17 citations1995: 13 citations1996: 14 citations1997: 12 citations1998: 25 citations1999: 33 citations2000: 33 citations2001: 34 citations2002: 63 citations2003: 61 citations2004: 99 citations2005: 132 citations2006: 118 citations2007: 128 citations2008: 156 citations2009: 130 citations2010: 181 citations2011: 177 citations2012: 163 citations2013: 171 citations2014: 188 citations2015: 190 citations2016: 180 citations2017: 159 citations2018: 143 citations2019: 485 citations2020: 517 citations2021: 385 citations2022: 319 citations2023: 251 citations2024: 416 citations2025: 194 citations2026: 19 citations1981: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,899 citing papers, 23.8% of this breakdownUnited Kingdom: 918 citing papers, 11.5% of this breakdownCanada: 551 citing papers, 6.9% of this breakdownChina: 364 citing papers, 4.6% of this breakdownAustralia: 356 citing papers, 4.5% of this breakdownGermany: 342 citing papers, 4.3% of this breakdownItaly: 295 citing papers, 3.7% of this breakdownNetherlands: 287 citing papers, 3.6% of this breakdownFrance: 223 citing papers, 2.8% of this breakdownSpain: 184 citing papers, 2.3% of this breakdownSwitzerland: 161 citing papers, 2% of this breakdownSweden: 148 citing papers, 1.9% of this breakdown
0%23.8%Other 28.1%

Fields

  • Medicine67%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Neuroscience5.2%
  • Health Professions4.6%
  • Decision Sciences3.4%
  • Psychology2.9%
  • Other11.4%

Topics

  • Reproductive Health and Contraception4.6%
  • Parkinson's Disease Mechanisms and Treatments3.6%
  • Global Maternal and Child Health2%
  • Meta-analysis and systematic reviews1.7%
  • Neurological disorders and treatments1.2%
  • Maternal and Perinatal Health Interventions1.2%
  • Other85.7%

Coauthors

All papers

Open in search
  1. Bias and causal associations in observational research

    Authors: , - The Lancet 2002 cited by 1,525

  2. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angel Figueroa, Ani Arkun, Matthew Brodsky, William G. Ondo, Christine Hunter, Joohi Jimenez‐Shahed, Alicia Palao, Janis M. Miyasaki, Julie So, James W. Tetrud, Liza Reys, Katharine Smith, Carlos Singer, Anita Blenke, David Russell, Candace Cotto, Joseph H. Friedman, Margaret C. Lannon, Lin Zhang, Edward Drasby, Rajeev Kumar, Thyagarajan Subramanian, Donna Stuppy Ford, David A. Grimes, Diane Côté, Jennifer Conway, Andrew Siderowf, Marian L. Evatt, Barbara Sommerfeld, Abraham Lieberman, Michael S. Okun, Ramon L. Rodriguez, Stacy Merritt, Camille Swartz, W. R. Wayne Martin, Pamela King, Natividad Stover, Stephanie Guthrie, Ray L. Watts, Anwar Ahmed, Hubert H. Fernandez, Adrienna Winters, Zoltán Mari, Ted M. Dawson, Becky Dunlop, Andrew Feigin, Barbara Shannon, Melissa J. Nirenberg, Mattson Ogg, Samuel A. Ellias, Cathi-Ann Thomas, Karen Frei, Iván Bódis-Wollner, Sofya Glazman, Thomas A. Mayer, Robert A. Hauser, Rajesh Pahwa, April Langhammer, Ranjit Ranawaya, Lorelei Derwent, Kapil D. Sethi, Buff Farrow, Rajan Prakash, Irene Litvan, Annette Robinson, Alok Sahay, Maureen Gartner, Vanessa K. Hinson, Samuel Markind, Melisa Pelikan and 62 more - JAMA Neurology 2014 cited by 395

  3. Blinding in randomised trials: hiding who got what

    Authors: , - The Lancet 2002 cited by 939

  4. Classification and staging of Parkinson's disease using video-based eye tracking

    Authors: , , , , , , , , , , , , , , , , , , - Parkinsonism & Related Disorders 2023 cited by 69

  5. Refining clinical diagnosis with likelihood ratios

    Authors: , - The Lancet 2005 cited by 828

  6. Caffeine as symptomatic treatment for Parkinson disease (Café-PD)

    Authors: , , , , , , , , , , , , - Neurology 2017 cited by 134

  7. Integrated Care in Parkinson's Disease: A Systematic Review and Meta‐Analysis

    Authors: , , , , , , , , , , , , - Movement Disorders 2020 cited by 129

  8. An overview of clinical research: the lay of the land

    Authors: , - The Lancet 2002 cited by 733

  9. Generation of allocation sequences in randomised trials: chance, not choice

    Authors: , - The Lancet 2002 cited by 763

  10. Canadian guideline for Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , - Canadian Medical Association Journal 2019 cited by 167

  11. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John F. Robinson, Ekaterina Rogaeva, Demetrios J. Sahlas, Gustavo Saposnik, Michael J. Strong, Richard H. Swartz, David F. Tang‐Wai, Maria Carmela Tartaglia, Angela K. Troyer, Hlin Kvartsberg, Henrik Zetterberg, Douglas P. Munoz, the ONDRI Investigators, Mario Masellis - Alzheimer s & Dementia 2023 cited by 55

  12. Small and Large Magnetic Resonance Imaging–Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2022 cited by 27

  13. Allocation concealment in randomised trials: defending against deciphering

    Authors: , - The Lancet 2002 cited by 904

  14. Sample size slippages in randomised trials: exclusions and the lost and wayward

    Authors: , - The Lancet 2002 cited by 640

  15. Uses and abuses of screening tests

    Authors: , - The Lancet 2002 cited by 542

  16. Cohort studies: marching towards outcomes

    Authors: , - The Lancet 2002 cited by 490

  17. Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons

    Authors: , , , , , , , , - Journal of Neuroscience 2007 cited by 303

  18. The Comparative Safety of Legal Induced Abortion and Childbirth in the United States

    Authors: , - Obstetrics and Gynecology 2012 cited by 402

  19. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices

    Authors: , , - American Journal of Obstetrics and Gynecology 1999 cited by 394

  20. Reproducibility of data-driven Parkinson's disease subtypes for clinical research

    Authors: , , , , , , - Parkinsonism & Related Disorders 2018 cited by 85

  21. Unsafe abortion: the preventable pandemic

    Authors: , , , , , , - The Lancet 2006 cited by 893

  22. The Ontario Neurodegenerative Disease Research Initiative (ONDRI)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2016 cited by 113

  23. Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Demetrios J. Sahlas, Gustavo Saposnik, Dallas Seitz, Christen Shoesmith, Thomas Steeves, Stephen C. Strother, Kelly M. Sunderland, Richard H. Swartz, Brian Tan, David F. Tang‐Wai, Maria Carmela Tartaglia, John Turnbull, Lorne Zinman, Douglas P. Munoz, the ONDRI Investigators, Sabrina Adamo, Robert Bartha, Courtney Berezuk, Alanna Black, Michael Borrie, Susan E. Bronskill, Dennis E. Bulman, Leanne K. Casaubon, Ben Cornish, Sherif Defrawy, Allison A. Dilliott, Roger A. Dixon, Sali M.K. Farhan, Frederico Faria, Julia Fraser, Morris Freedman, Mahdi Ghani, Barry Greenberg, Hassan Haddad, Ayman Hassan, Wendy Hatch, Rob Hegele, Melissa F. Holmes, Chris Hudson, Mandar Jog, Peter Kleinstiver, Donna Kwan, Elena Leontieva, Brian Levine, Efrem D. Mandelcorn, Ed Margolin, Bill McIlroy, Manuel Montero‐Odasso, David G. Munoz, Nuwan D. Nanayakkara, Miracle Ozzoude, Joel Ramirez, Natalie Rashkovan, John F. Robinson, Ekaterina Rogaeva, Yanina Sarquis Adamson, Christopher J.M. Scott, Michael J. Strong, Sujeevini Sujanthan, Sean Symons, Athena Theyers, Angela K. Troyer, Karen Van Ooteghem, John Woulfe, Mojdeh Zamyadi - Brain Communications 2023 cited by 36

  24. Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony E. Lang, Brian Levine, Wendy Lou, Jennifer Mandzia, Connie Marras, William E. McIlroy, Manuel Montero‐Odasso, David G. Munoz, Douglas P. Munoz, J. B. Orange, David S. Park, Stephen Pasternak, Frederico Pieruccini‐Faria, Tarek K. Rajji, Angela Roberts, John F. Robinson, Ekaterina Rogaeva, Demetrios J. Sahlas, Gustavo Saposnik, Christopher J.M. Scott, Dallas Seitz, Christen Shoesmith, Thomas Steeves, Michael J. Strong, Stephen C. Strother, Richard H. Swartz, Sean Symons, David F. Tang‐Wai, Maria Carmela Tartaglia, Angela K. Troyer, John Turnbull, Lorne Zinman, Paula McLaughlin, Mario Masellis, Malcolm A. Binns, the ONDRI Investigators - Alzheimer s & Dementia 2022 cited by 31